We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amicus Briefs: Don’t Punish Apotex for Complying With BPCIA Rules
Amicus Briefs: Don’t Punish Apotex for Complying With BPCIA Rules
Generic and biosimilars manufacturers are coming to the aid of Apotex in its drawn-out patent fight with Amgen, arguing that a district court order effectively punishes the Canadian drugmaker for following the law.